Surgical instruments maker NuOrtho Surgical Inc. won 510(k) clearance from the Food & Drug Administration for its Ceruleau electrosurgical probe.
The device is the first of the Fall River, Mass.-based company’s tissue preservation surgical tools. The Ceruleau is a 3.5mm arthroscopic radio frequency electrosurgical probe designed to use low-level radio frequencies to smooth and contour frayed or torn cartilage while avoiding damage to adjacent cartilage, according to a press release.
Late last month, NuOrho landed $250,000 in an offering of debt, options and warrants, part of a hoped-for $1.5 million round. The company raised $1 million each in its Series A and Series B rounds last year. It has yet to post revenues, according to a May 21 filing.